Take Solutions Ltd
Healthcare | Small Cap
Take Solutions Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strengths in solvency and growth, particularly in earnings per share. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. While the company's earnings per share growth and equity-related solvency metrics are positive, its poor liquidity and profitability raise concerns. The company's ability to meet its short-term obligations and generate profits is questionable. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further affect the company's financial stability. The company needs to address these weaknesses to ensure long-term sustainability and growth.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.00
- Financial Ratio2.80
- Profitability Ratio2.00
- Efficiency Ratio4.67
- Coverage Ratio2.00
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentWeak
- Risk AssessmentWeak
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayNeutral
- 1 WeekBearish
- 1 MonthNeutral
Take Solutions Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strengths in solvency and growth, particularly in earnings per share. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. While the company's earnings per share growth and equity-related solvency metrics are positive, its poor liquidity and profitability raise concerns. The company's ability to meet its short-term obligations and generate profits is questionable. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further affect the company's financial stability. The company needs to address these weaknesses to ensure long-term sustainability and growth.
Overall Valuation Score
P/E RATIO (TTM)
166.83
Industry Median
34.78
Small Cap Median
28.42
P/E RATIO
41.14
P/B RATIO
14.30
Industry Median
11.62
Small Cap Median
8.93
P/S RATIO
8.23
Industry Median
6.05
Small Cap Median
3.87
Others
PEG RATIO
0.00
EV/EBITDA RATIO
40.38
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹30.03 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company exhibits mixed growth performance. While earnings per share (EPS) growth is strong, revenue, operating profit, asset, and net income growth rates are low. This suggests that while the company is improving its profitability on a per-share basis, it is not experiencing overall growth in key areas such as revenue and assets. The healthcare sector's growth is influenced by factors such as demographics, healthcare spending, and technological advancements. The company needs to focus on driving revenue and asset growth to ensure long-term sustainability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | -15.37 | -71.15 | -97.88 | -100 | |
| Operating Profit Growth Rate | -109.59 | -371.43 | 5.26 | -65 | -71.43 |
| Earnings Per Share (EPS) Growth | 73.04 | -87.18 | 19.32 | -131.27 | -71.15 |
| Asset Growth Rate | -33.02 | -81.68 | -60.71 | -59.09 | 0 |
| Net Income Growth Rate | 73.78 | -87.21 | 20 | -130.83 | -70.27 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial metrics show a mixed performance. Cash earnings per share is low, and book value per share is also at a minimal level. This could be due to poor profitability, asset write-downs, or excessive dividend payments. These factors can erode shareholder value. The healthcare sector's financial performance is influenced by factors such as reimbursement rates, patient volumes, and regulatory changes. The company needs to focus on improving its profitability and managing its assets effectively to enhance its financial metrics.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | -52.13 | -6 | -5.33 | 2.47 | 0.27 |
| Cash Earnings Per Share (Cash EPS) | -46.8 | -5.53 | -7.93 | 2.47 | 0.73 |
| Book Value Per Share | 12.07 | 7.27 | -0.6 | 1.4 | 2.07 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 31.2 | 31.9 | 7.8 | 0 | 0 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios are generally weak across all metrics. Low gross profit, return on capital employed (ROCE), return on equity (ROE), return on assets (ROA), operating margin, and net margin indicate significant challenges in generating profits from its operations. This could be due to high operating expenses, competitive pressures, or inefficient operations. The healthcare sector's profitability is influenced by factors such as reimbursement rates, patient volumes, and regulatory changes. The company needs to address these factors to improve its overall profitability.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | -11.15 | -19.05 | -525 | -3.7 | |
| Return on Capital Employed (ROCE) | -6 | -14 | -22 | 19 | |
| Return on Equity (ROE) | -432.04 | -91.74 | 35.48 | ||
| Return on Assets (ROA) | 0.57 | -8.48 | -22.73 | -5.56 | |
| Operating Margin | 1.07 | -10.05 | -500 | -3.7 | |
| Net Margin | -119.39 | -52.91 | -3000 | 20.37 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios present a mixed picture. While days sales in inventory and receivable days suggest efficient management of inventory and collections, the fixed asset, inventory, receivables, and capital turnover ratios are low, indicating underutilization of assets and potential inefficiencies in operations. This could be due to underinvestment in technology or poor management of resources. The healthcare sector's operational complexities, including patient scheduling and resource allocation, could affect these ratios. The company should focus on improving asset utilization to enhance overall efficiency.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 6.49 | 2.59 | 0.13 | ||
| Inventory Turnover Ratio | 1155.56 | 314.69 | 31.65 | 17.5 | N/A |
| Receivables Turnover Ratio | 2.54 | 3.39 | 0.22 | 0 | 490.91 |
| Days Sales in Inventory Ratio | 0.32 | 1.16 | 11.53 | 20.86 | N/A |
| Receivable Days | 143.7 | 107.67 | 1659.09 | 0.74 | |
| Capital Turnover Ratio | 3.13 | 1.48 | 4.55 | 0 | 1.74 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios are weak, particularly the interest coverage ratio. The interest coverage ratio being low indicates difficulties in meeting interest obligations. This raises concerns about the company's ability to service its debt. The healthcare sector's capital-intensive nature and regulatory requirements can affect coverage ratios. The company should focus on improving its earnings and managing its debt effectively to enhance its coverage ratios.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | -25.86 | -13.14 | -57 | 19.5 | N/A |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is strong, primarily driven by high equity ratio. The debt and debt to asset ratio being zero suggests that the company is not using debt to finance its assets. This can reduce financial risk. With a solid equity base, the company appears financially stable and less vulnerable to economic downturns. The healthcare sector's inherent stability, due to consistent demand for services, can further support the company's solvency, but this also reflects a missed opportunity to leverage debt for growth.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.14 | 0.15 | 11.23 | 0 | 0 |
| Debt to Equity Ratio | 0.16 | 0.18 | -1.1 | 0 | 0 |
| Equity Ratio | 0.86 | 0.85 | -10.23 | 1 | 1 |
| Debt To Asset Ratio | 0.02 | 0.08 | 0.11 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position appears weak across all measured metrics. The current, quick, and cash ratios are all at minimal levels, suggesting a limited ability to meet short-term obligations with available assets. The operating cash flow ratio also indicates challenges in generating sufficient cash from operations to cover current liabilities. This situation could restrict the company's financial flexibility and increase its dependence on external financing. However, the healthcare industry's specific working capital cycles should be considered when evaluating these ratios.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.45 | 0.67 | 2.25 | 7.2 |
| Quick Ratio | 1.1 | 1.44 | 0.66 | 2.25 | 7.2 |
| Cash Ratio | 0.03 | 0.12 | 0.01 | 0.21 | 0.06 |
| Operating Cash Flow Ratio | 0.03 | 0.21 | 0.1 | -1 | -0.8 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Yash Optics & Lens Ltd | 6.15 | 29.97 | Neutral | 14.74 | 3.65 | 9.05 |
| 2 | Take Solutions Ltd | 3.89 | 41.14 | Neutral | -2.00 | 0.18 | 11.00 |
The management of Take Solutions Ltd. faces significant challenges, reflected in declining financial performance and operational inefficiencies. The company's inability to sustain sales growth and profitability raises concerns about strategic decision-making. While promoter holding remains consistent, the decrease in institutional interest suggests a lack of confidence in management's ability to improve the company's prospects. These factors contribute to a negative outlook on the management's effectiveness.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| CONS | Sales Growth | Declining Sales from 2019 to 2025 | Sales have decreased significantly, indicating potential issues with market positioning or product offerings. |
| Operating Profit Margin | Negative OPM in recent years | The operating profit margin is also negative, which indicates ineffecient operations. | |
| Institutional Interest | Decreased FII and DII holdings | Decreased institutional interest indicates a lack of confidence in the company's future performance. |
Financial Performance & Growth
Take Solutions exhibits significant financial performance concerns. Sales have sharply declined, leading to substantial losses. The trend in sales and profit growth indicates operational difficulties. The company's revenue has contracted dramatically, and profitability metrics remain negative, signaling potential long-term sustainability challenges.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sales (₹ Cr) | 862 | 1657 | 634 | 189 | 66 | 0 |
| Net Profit (₹ Cr) | 89 | 161 | -414 | -100 | -120 | 37 |
Capital Efficiency & Returns
The capital efficiency and returns for Take Solutions Ltd are poor. The company has negative ROCE, indicating it is not effectively utilizing capital. The inability to generate positive returns raises concerns about its long-term financial viability.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 13% | 15% | -7% | -14% | -21% | 11% |
Financial Health & Prudence
Take Solutions Ltd shows signs of weak financial health. While the company has reduced its borrowings, consistent losses and negative profitability impact its ability to manage financial obligations. The absence of dividend payouts reflects the company's financial strain.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings (₹Cr) | 250 | 348 | 207 | 46 | 37 | 0 |
| Dividend Payout % | 16% | 11% | 0% | 0% | 0% | 0% |
Shareholding & Ownership Structure
The shareholding structure of Take Solutions Ltd reveals mixed signals. Promoter holding remains consistent, indicating continued alignment with the company's direction. However, the decline in FII and DII holdings suggests decreasing institutional confidence.
| Metric | Jun 2022 | Mar 2025 |
|---|---|---|
| Promoter Holding (%) | 53.41% | 53.41% |
| FII Holding (%) | 0.75% | 0.00% |
| DII Holding (%) | 0.04% | 0.01% |
Take Solutions faces high risk due to negative profitability, declining sales, and inconsistent cash flows. Operational inefficiencies, reflected in negative ROCE, and decreasing institutional interest increase the risk profile. The company's weak financial performance and market indicators warrant careful monitoring and strategic adjustments to mitigate these risks.
Accounting quality red flags
There are notable fluctuations in other income, with significant negative values in certain periods and positive values in others. These fluctuations may impact the stability and predictability of earnings. Investors should scrutinize these items and assess their impact on the company’s underlying profitability. The lack of consistent positive other income raises concerns.
Foreign exchange or interest rate exposure
The company's exposure to foreign exchange or interest rate risks is difficult to assess definitively with the available data. However, the presence of other income and interest expenses suggests potential involvement in activities that could be affected by exchange rate or interest rate fluctuations. Given the limited information, a neutral stance is appropriate.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1029.73Bullish
- SMA 2029.68Bullish
- SMA 5029.75Bullish
- EMA 1029.79Bullish
- EMA 2029.74Bullish
- EMA 5029.75Bullish
- DEMA 1029.90Bullish
- DEMA 2029.77Bullish
- DEMA 5029.70Bullish
- TEMA 1030.01Bullish
- TEMA 2029.83Bullish
- TEMA 5029.72Bullish
- MACD0.04Bullish
- ADX48.78Strong Trend
- IndicatorValueSignal
- RSI62.99Neutral
- CCI232.40Overbought
- ROC 92.74Bullish
- ROC 141.77Bullish
- ROC 252.15Bullish
- Stoch K78.68Neutral
- Stoch D66.47Neutral
- IndicatorValueSignal
- BB Upper30.16Overbought
- BB Middle29.68Neutral
- BB Lower29.21Neutral
- ATR0.58High Volatility
- IndicatorValueSignal
- MFI25.35Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1029.75Bullish
- SMA 2029.76Bullish
- SMA 5029.77Bullish
- EMA 1029.82Bullish
- EMA 2029.78Bullish
- EMA 5029.86Bullish
- DEMA 1029.91Bullish
- DEMA 2029.79Bullish
- DEMA 5029.48Bullish
- TEMA 1030.01Bullish
- TEMA 2029.85Bullish
- TEMA 5030.10Bullish
- MACD0.02Bullish
- ADX31.20Strong Trend
- IndicatorValueSignal
- RSI59.85Neutral
- CCI232.86Overbought
- ROC 92.70Bullish
- ROC 142.56Bullish
- ROC 253.08Bullish
- Stoch K75.05Neutral
- Stoch D68.89Neutral
- IndicatorValueSignal
- BB Upper30.23Overbought
- BB Middle29.76Neutral
- BB Lower29.28Neutral
- ATR0.77High Volatility
- IndicatorValueSignal
- MFI38.59Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1029.77Bullish
- SMA 2029.75Bullish
- SMA 5029.22Bullish
- EMA 1029.80Bullish
- EMA 2029.81Bullish
- EMA 5030.75Bearish
- DEMA 1029.84Bullish
- DEMA 2029.71Bullish
- DEMA 5027.88Bullish
- TEMA 1029.90Bullish
- TEMA 2029.97Bullish
- TEMA 50N/AN/A
- MACD-0.08Bullish
- ADX18.85Weak Trend
- IndicatorValueSignal
- RSI55.23Neutral
- CCI181.06Overbought
- ROC 92.49Bullish
- ROC 141.84Bullish
- ROC 25-0.10Bearish
- Stoch K64.74Neutral
- Stoch D59.75Neutral
- IndicatorValueSignal
- BB Upper30.23Overbought
- BB Middle29.75Neutral
- BB Lower29.28Neutral
- ATR1.07High Volatility
- IndicatorValueSignal
- MFI25.08Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 1029.60Bullish
- SMA 2029.82Bearish
- SMA 5035.67Bearish
- SMA 10038.64Bearish
- SMA 20031.92Bearish
- EMA 1029.69Bullish
- EMA 2030.26Bearish
- EMA 5033.41Bearish
- EMA 10034.83Bearish
- EMA 20031.74Bearish
- DEMA 1029.56Bullish
- DEMA 2028.43Bullish
- DEMA 5029.49Bullish
- DEMA 10035.81Bearish
- DEMA 20038.80Bearish
- TEMA 1029.83Bearish
- TEMA 2029.42Bullish
- TEMA 5026.53Bullish
- TEMA 10030.93Bearish
- TEMA 20040.32Bearish
- MACD-1.17Bullish
- ADX28.64Strong Trend
- IndicatorValueSignal
- RSI39.42Neutral
- CCI-39.00Neutral
- ROC 14-3.38Bearish
- ROC 254.97Bullish
- Stoch K41.49Neutral
- Stoch D40.14Neutral
- IndicatorValueSignal
- BB Upper31.11Neutral
- BB Middle29.82Neutral
- BB Lower28.53Neutral
- ATR1.53High Volatility
- IndicatorValueSignal
- MFI19.07Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2038.94Bearish
- SMA 5028.52Bullish
- EMA 2035.23Bearish
- EMA 5030.62Bearish
- DEMA 2035.88Bearish
- DEMA 5038.15Bearish
- TEMA 2031.29Bearish
- TEMA 5041.54Bearish
- MACD-0.30Bearish
- ADX33.60Strong Trend
- IndicatorValueSignal
- RSI47.96Neutral
- CCI6.03Neutral
- ROC 14-13.75Bearish
- ROC 25-16.04Bearish
- Stoch K25.43Neutral
- Stoch D22.40Neutral
- IndicatorValueSignal
- BB Upper53.13Neutral
- BB Middle38.94Neutral
- BB Lower24.76Neutral
- ATR4.45Low Volatility
- IndicatorValueSignal
- MFI69.73Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 639.47Bearish
- SMA 1227.49Bullish
- SMA 2421.11Bullish
- EMA 635.36Bearish
- EMA 1230.45Bullish
- EMA 2425.96Bullish
- DEMA 639.16Bearish
- DEMA 1238.04Bearish
- DEMA 2428.63Bullish
- TEMA 637.12Bearish
- TEMA 1241.85Bearish
- TEMA 2437.94Bearish
- MACD-6.35Bullish
- ADX25.89Strong Trend
- IndicatorValueSignal
- RSI48.08Neutral
- CCI106.80Overbought
- ROC 2535.09Bullish
- ROC 506.21Bullish
- Stoch K49.53Neutral
- Stoch D25.56Neutral
- IndicatorValueSignal
- BB Upper47.79Neutral
- BB Middle21.29Neutral
- BB Lower-5.20Neutral
- ATR7.72High Volatility
- IndicatorValueSignal
- MFI91.60Overbought